Grace Therapeutics
- Biotech or pharma, therapeutic R&D
Grace Therapeutics is a late-stage biopharma focused on rare and orphan diseases. GTx-104 (critical care iv program) for subarachnoid hemorrhage reported positive Phase 3 data and gearing up for NDA submission in 2Q25. GTx-102 for ataxia telangiectasia recently aligned with FDA on its next pivotal Phase 3 trial. Interest in-licensing hospital programs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}